Inventor

BLACKBURN ANTHONY C

US24 patents

⚠️ This page may combine multiple inventors who share the name “BLACKBURN ANTHONY C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BLACKBURN ANTHONY C

ARENA PHARM INC

Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disorders

Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders

Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders

Crystalline forms and processes for the preparation of cannabinoid receptor modulators

Crystalline forms and processes for the preparation of cannabinoid receptor modulators

Cannabinoid receptor modulators

Cannabinoid receptor modulators

Cannabinoid receptor modulators

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto

Cannabinoid receptor modulators

Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders

Crystalline forms and processes for the preparation of cannabinoid receptor modulators

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto

Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders related thereto

Cannabinoid receptor modulators

Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disorders

Modified-release dosage forms of 5-HT2C agonists useful for weight management

Modified-release dosage forms of 5-HT2C agonists useful for weight management

BLACKBURN ANTHONY C

Crystalline forms and processes for the preparation of cannabinoid receptor modulators

Non-hygroscopic salts of 5-HT2C agonists

Salts of lorcaserin with optically active acids

Processes for the preparation of 5-HT2C receptor agonists

THATTE JAYANT

Cannabinoid receptor modulators